Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin...
27 insider purchases on record · latest filing 2026-07-20.
Insiders have also filed 69 sale transactions at FULC.